Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.

DELRAY BEACH, Fla., April 08, 2019 (GLOBE NEWSWIRE) — Exactus Inc. (OTCQB: EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact Biosciences Corp.

Jonathan Gilbert, cannabis industry veteran, and founder and former CEO of SOL Global Investments Corp. (CSE:SOL) (Frankfurt:9SB) (OTCQB:SOLCF), whose wholly owned subsidiary, Scythian Biosciences Inc. (“SBI”), is seeking to list SBI as a new public company on the Canadian Stock Exchange (“CSE”) following a successful capital raise and spinout.

Philip Young, CEO of Exactus said, “We are proud to compliment Jonathan on his new venture and believe there are many great benefits from the use of cannabinoids. There is a large gap in the availability of controlled clinical trial data demonstrating the health benefits of this amazing plant, and we look forward to seeing the research

... read more at: https://www.globenewswire.com/news-release/2019/04/08/1798856/0/en/Exactus-Applauds-Executive-Chairman-Jonathan-Gilbert-on-Launch-of-Impact-Biosciences-Corp.html